Lance E. D'Amico - 25 Apr 2025 Form 4 Insider Report for AMPHENOL CORP /DE/ (APH)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
29 Apr 2025, 16:44:45 UTC
Prior SEC filing
29 Jan 2025
Next SEC filing
13 May 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Lance E. D'Amico

Key filing fact

Lance E. D'Amico filed Form 4 for AMPHENOL CORP /DE/ (APH) on 29 Apr 2025.

Key facts

  • This page summarizes Lance E. D'Amico's Form 4 filing for AMPHENOL CORP /DE/ (APH).
  • 6 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 29 Apr 2025, 16:44.

Change

  • Previous filing in this sequence was filed on 29 Jan 2025.
  • Current net transaction value: -$11,049,776.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

APH transaction

Class A Common Stock

Options Exercise

Transaction value
$3,914,750
Shares
+175,000
Change %
+340%
Price
$22.37
Shares after
226,400
Date
25 Apr 2025
Ownership
Direct
APH transaction

Class A Common Stock

Sale

Transaction value
$13,348,948
Shares
-175,000
Change %
-77%
Price
$76.28
Shares after
51,400
Date
25 Apr 2025
Ownership
Direct
Footnotes
F1, F2
APH transaction

Class A Common Stock

Options Exercise

Transaction value
$671,100
Shares
+30,000
Change %
Price
$22.37
Shares after
30,000
Date
25 Apr 2025
Ownership
By Lance E. D'Amico 2024 Irrevocable Trust
APH transaction

Class A Common Stock

Sale

Transaction value
$2,286,678
Shares
-30,000
Change %
-100%
Price
$76.22
Shares after
0
Date
25 Apr 2025
Ownership
By Lance E. D'Amico 2024 Irrevocable Trust
Footnotes
F1, F3
APH holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
25,000
Date
25 Apr 2025
Ownership
By Lance E. Damico 2025 GRAT #1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

APH transaction Derivative

Stock Option

Options Exercise

Transaction value
$0
Shares
-175,000
Change %
-58%
Price
$0.000000
Shares after
125,000
Date
25 Apr 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
175,000
Exercise price
$22.37
APH transaction Derivative

Stock Option

Options Exercise

Transaction value
$0
Shares
-30,000
Change %
-30%
Price
$0.000000
Shares after
70,000
Date
25 Apr 2025
Ownership
By Lance E. D'Amico 2024 Irrevocable Trust
Underlying class
Class A Common Stock
Underlying amount
30,000
Exercise price
$22.37
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F2

This transaction was executed in multiple trades ranging from $76.0101 to $76.4810.

Footnote F3

This transaction was executed in multiple trades ranging from $75.9300 to $76.3975.

Footnote F4

These options were transferred to the Lance E. D'Amico 2024 Irrevocable Trust for no consideration.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .